Stock-Based Compensation Plans |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Share-Based Payment Arrangement [Abstract] | |
| Stock-Based Compensation Plans | 13. Stock-Based Compensation PlansFor the three months ended March 31, 2026 and 2025, the Company recognized stock-based compensation expense of $8.9 million and $10.6 million, respectively, resulting primarily from stock options, restricted stock units, and performance-based restricted stock units, in the Condensed Consolidated Statements of Income. During the three months ended March 31, 2026, the Company granted 2.1 million options at a weighted-average exercise price of $9.56 and 5.0 million performance-based restricted stock units and restricted stock units at a weighted-average grant date fair value of $9.67. As of March 31, 2026, the Company had 13.9 million outstanding options at a weighted-average exercise price of $12.93, of which 8.2 million options were exercisable at a weighted-average exercise price of $14.34. The Company had 11.4 million outstanding performance-based restricted stock units (based on target performance) and restricted stock units at a weighted-average grant date fair value of $10.86 as of March 31, 2026. |